Alprostadil
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Alprostadil and local guidelines before prescribing.
Mechanism
Prostaglandin E1 vasodilator.
Uses
Erectile dysfunction (intracavernosal), patent ductus arteriosus maintenance in neonates, severe peripheral arterial disease (selected).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Penile pain, priapism, apnoea in neonates, hypotension.
Interactions
Antihypertensives; anticoagulants.
Contraindications and cautions
Priapism risk, sickle cell disease
Monitoring
BP, apnoea in neonates
Pregnancy and breastfeeding
Not applicable
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive
Special advice
Priapism lasting over 4 hours is an emergency; neonatal use requires ventilatory support.
More from the textbook: uses, cautions and other points
- Treatment - prostaglandin E (alprostadil or dinoprostone) infusion to reopen the duct (side effect - apnoea); urgent transfer to a cardiac centre.
Paediatrics: Neonatology - Drugs and the duct - prostaglandin E1 (alprostadil) keeps the duct open in duct-dependent heart lesions; NSAIDs (ibuprofen, indomethacin) or paracetamol close a PDA in preterm babies; NSAIDs late in pregnancy can close the fetal duct early.
Cardiology: Anatomy Physiology and Pharmacology - Shunt that closes within days of birth, kept open by alprostadil | Ductus arteriosus
Cardiology: Anatomy Physiology and Pharmacology - Prostaglandin E (alprostadil or dinoprostone) infusion: Keeps the duct open, or reopens it, until surgery or a catheter procedure.
Cardiology: Congenital heart disease - Alprostadil / dinoprostone Duct-dependent lesions (neonate) | IV infusion, starting low (around 5–10 nanograms/kg/min) and titrated; higher doses for a collapsing baby. Apnoea risk - be ready to ventilate. Use BNFc and the regional protocol.
Cardiology: Congenital heart disease - Alprostadil | Duct-dependent congenital heart disease; apnoea.
Paediatrics: Respiratory and heart problems in children - Alprostadil / dinoprostone infusion | Keeps the ductus arteriosus open in duct-dependent heart disease; apnoea.
Paediatrics: Neonatology - Clinical: patent ductus arteriosus - continuous "machinery" murmur, common in preterm infants (closed with NSAIDs such as indometacin or ibuprofen, or paracetamol); prostaglandin E₁ (alprostadil) keeps the duct open in duct-dependent congenital heart disease (e.g. transposition, critical coarctation).
Anatomy: Embryology and development
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Congenital heart disease (2 mentions)
- Paediatrics: Respiratory and heart problems in children (1 mention)
- Paediatrics: Neonatology (2 mentions)
- Integrated cardiology chapter (2 mentions)
- Integrated paediatrics chapter (3 mentions)
- Anatomy: Embryology and development (2 mentions)
- 0240-embryology-and-congenital-anatomy (2 mentions)